You are here
,

Insmed's treatment-resistant lung disease drug gets FDA approval

  • Saturday, 29 September 2018
  • Posted by Aftab Ahmad
  • 0 Comments
The U.S. Food and Drug Administration on Friday approved Insmed Inc's lead drug to treat a rare, chronic lung disease, making it the first approved treatment in the United States for the condition.


from Reuters: Health News https://ift.tt/2ItzRFT

Aftab Ahmad

We are.., This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

No comments:

Leave a Reply